1. Home
  2. ATHE vs SHFS Comparison

ATHE vs SHFS Comparison

Compare ATHE & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • SHFS
  • Stock Information
  • Founded
  • ATHE 1997
  • SHFS 2015
  • Country
  • ATHE Australia
  • SHFS United States
  • Employees
  • ATHE N/A
  • SHFS N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • SHFS Finance: Consumer Services
  • Sector
  • ATHE Health Care
  • SHFS Finance
  • Exchange
  • ATHE Nasdaq
  • SHFS Nasdaq
  • Market Cap
  • ATHE 21.4M
  • SHFS 20.8M
  • IPO Year
  • ATHE N/A
  • SHFS N/A
  • Fundamental
  • Price
  • ATHE $4.75
  • SHFS $0.50
  • Analyst Decision
  • ATHE Strong Buy
  • SHFS
  • Analyst Count
  • ATHE 2
  • SHFS 0
  • Target Price
  • ATHE $8.00
  • SHFS N/A
  • AVG Volume (30 Days)
  • ATHE 1.3M
  • SHFS 345.8K
  • Earning Date
  • ATHE 02-15-2025
  • SHFS 11-12-2024
  • Dividend Yield
  • ATHE N/A
  • SHFS N/A
  • EPS Growth
  • ATHE N/A
  • SHFS N/A
  • EPS
  • ATHE N/A
  • SHFS 0.10
  • Revenue
  • ATHE $2,681,669.00
  • SHFS $15,658,629.00
  • Revenue This Year
  • ATHE N/A
  • SHFS N/A
  • Revenue Next Year
  • ATHE N/A
  • SHFS N/A
  • P/E Ratio
  • ATHE N/A
  • SHFS $4.82
  • Revenue Growth
  • ATHE 2.63
  • SHFS 7.78
  • 52 Week Low
  • ATHE $1.00
  • SHFS $0.30
  • 52 Week High
  • ATHE $5.87
  • SHFS $1.10
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 75.45
  • SHFS 65.58
  • Support Level
  • ATHE $2.76
  • SHFS $0.37
  • Resistance Level
  • ATHE $5.14
  • SHFS $0.53
  • Average True Range (ATR)
  • ATHE 0.42
  • SHFS 0.04
  • MACD
  • ATHE 0.15
  • SHFS 0.01
  • Stochastic Oscillator
  • ATHE 71.14
  • SHFS 77.78

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.

Share on Social Networks: